A. G. Yusufov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
A. G. Yusufov has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Sergey Vladislavovich Kotov
N. I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Moscow Multidisciplinary Clinical Centre “Kommunarka
22 shared publications - R. I. Gouspanov
Pirogov Russian National Research Medical University ; “Kommunarka” Moscow Multidisciplinary Clinical Centre
18 shared publications - S. A. Pulbere
Pirogov Russian National Research Medical University (Pirogov Medical University)
8 shared publications - D. A. Bogdanov
«Kommunarka» Moscow Multidisciplinary Clinical Centre
4 shared publications - I. Sh. Byadretdinov
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
4 shared publications - M. S. Zhilov
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
4 shared publications
Latest Publications
- Open Access
- 22 August 2026
- Published by Rostov State Medical University in Urology Herald
- Vol. 14 (4) , 24-33
Intraoperative blood loss and warm ischemia time as independent predictors of positive surgical margins following partial nephrectomy
Introduction. The presence of a positive surgical margin (PSM; R1 resection) following partial nephrectomy is associated with inferior oncological outcomes. Identification of risk factors for PSM and targeted optimization of modifiable variables may improve the surgical management of renal cell carcinoma and enhance long-term oncological outcomes. Objective. To identify risk factors for PSM following partial nephrectomy performed under warm ischemia, determine which of these factors are potentially modifiable, and evaluate the potential for reducing the incidence of PSM through targeted perioperative management. Materials & methods. A retrospective single-center study was conducted including 570 patients with localized renal cell carcinoma (clinical stages cT1–T2) who underwent partial nephrectomy between 2023 and 2025. Procedures were performed under warm ischemia using laparoscopic, retroperitoneoscopic, open, or robot-assisted approaches. Demographic, clinical, and pathological characteristics, the R.E.N.A.L. nephrometry score, surgical complexity, and key perioperative parameters—including warm ischemia time, estimated blood loss, incidence of collecting system injury, and PSM rate—were analyzed. Multivariable logistic regression, multivariable linear regression, and receiver operating characteristic (ROC) curve analyses were performed to identify independent predictors. Results . The overall incidence of PSM was 6.3% (n = 36). On univariable analysis, PSM was associated with larger tumor size, clinical stage cT1b, a higher R.E.N.A.L. nephrometry score, greater surgical complexity, prolonged warm ischemia time, and increased intraoperative blood loss. Multivariable analysis identified warm ischemia time and intraoperative blood loss as independent predictors of PSM. Threshold values associated with an increased risk of PSM were 28 minutes for warm ischemia time and 100 mL for intraoperative blood loss. Blood loss ≥100 mL was also associated with an increased risk of collecting system injury. Independent predictors of increased intraoperative blood loss included tumor size, the presence of atherosclerosis, operative time, warm ischemia time, surgical maneuver (tumor resection), and the renal artery-to-aorta diameter ratio (RA/Ao). An RA/Ao ratio ≥29% was found to predict intraoperative blood loss ≥100 mL. Conclusions. Warm ischemia time and intraoperative blood loss are independent predictors of PSM following partial nephrectomy performed under warm ischemia. Among these, intraoperative blood loss represents the only modifiable risk factor, underscoring the importance of meticulous preoperative planning and rigorous intraoperative hemostatic control. Attention should be paid to patients with atherosclerosis and an RA/Ao ratio ≥29%, as they are at increased risk of significant blood loss. Implementation of these strategies may reduce the incidence of PSM and improve oncological outcomes following partial nephrectomy. Further validation of these findings in prospective multicenter studies is warranted.
- 22 August 2026
- Published by Rostov State Medical University in Urology Herald
- Vol. 14 (4) , 24-33
Open AccessIntraoperative blood loss and warm ischemia time as independent predictors of positive surgical margins following partial nephrectomy
Introduction. The presence of a positive surgical margin (PSM; R1 resection) following partial nephrectomy is associated with inferior oncological outcomes. Identification of risk factors for PSM and targeted optimization of modifiable variables may improve the surgical management of renal cell carcinoma and enhance long-term oncological outcomes. Objective. To identify risk factors for PSM following partial nephrectomy performed under warm ischemia, determine which of these factors are potentially modifiable, and evaluate the potential for reducing the incidence of PSM through targeted perioperative management. Materials & methods. A retrospective single-center study was conducted including 570 patients with localized renal cell carcinoma (clinical stages cT1–T2) who underwent partial nephrectomy between 2023 and 2025. Procedures were performed under warm ischemia using laparoscopic, retroperitoneoscopic, open, or robot-assisted approaches. Demographic, clinical, and pathological characteristics, the R.E.N.A.L. nephrometry score, surgical complexity, and key perioperative parameters—including warm ischemia time, estimated blood loss, incidence of collecting system injury, and PSM rate—were analyzed. Multivariable logistic regression, multivariable linear regression, and receiver operating characteristic (ROC) curve analyses were performed to identify independent predictors. Results . The overall incidence of PSM was 6.3% (n = 36). On univariable analysis, PSM was associated with larger tumor size, clinical stage cT1b, a higher R.E.N.A.L. nephrometry score, greater surgical complexity, prolonged warm ischemia time, and increased intraoperative blood loss. Multivariable analysis identified warm ischemia time and intraoperative blood loss as independent predictors of PSM. Threshold values associated with an increased risk of PSM were 28 minutes for warm ischemia time and 100 mL for intraoperative blood loss. Blood loss ≥100 mL was also associated with an increased risk of collecting system injury. Independent predictors of increased intraoperative blood loss included tumor size, the presence of atherosclerosis, operative time, warm ischemia time, surgical maneuver (tumor resection), and the renal artery-to-aorta diameter ratio (RA/Ao). An RA/Ao ratio ≥29% was found to predict intraoperative blood loss ≥100 mL. Conclusions. Warm ischemia time and intraoperative blood loss are independent predictors of PSM following partial nephrectomy performed under warm ischemia. Among these, intraoperative blood loss represents the only modifiable risk factor, underscoring the importance of meticulous preoperative planning and rigorous intraoperative hemostatic control. Attention should be paid to patients with atherosclerosis and an RA/Ao ratio ≥29%, as they are at increased risk of significant blood loss. Implementation of these strategies may reduce the incidence of PSM and improve oncological outcomes following partial nephrectomy. Further validation of these findings in prospective multicenter studies is warranted.
- Open Access
- 13 January 2026
- Published by Rostov State Medical University in Urology Herald
- Vol. 13 (6) , 106-115
Repeat biopsy techniques and outcomes in the detection of clinically significant prostate cancer
Introduction. Prostate biopsy remains the definitive standard for confirming malignancy in the prostate. However, a negative initial biopsy does not rule out the presence of prostate cancer (PCa) during subsequent follow-up. This review provides an overview of current repeat biopsy techniques and assesses their diagnostic accuracy for clinically significant PCa (csPCa). Objective. To study various methods of repeated biopsy and evaluate the results of diagnosis of csPCa. Materials & Methods. A review of PubMed, eLibrary electronic databases was conducted from 2000 to 2024 to identify all relevant studies. The electronic search was limited to Russian and English, and the keywords used were: repeat prostate biopsy, clinically significant prostate cancer, fusion biopsy. Results. Currently, the following techniques can be used to perform a repeat prostate biopsy: saturation biopsy, micro-ultrasound, histoscanning and fusion biopsy. Saturation biopsy is associated with an increase in the number of complications, histoscanning has not shown high efficiency, micro-ultrasound is not so common and is limited by the number of studies. The advantage of diagnosing csPCa in patients with a previous negative histological conclusion is currently behind fusion biopsy. One of the advantages is the ability to choose one of three execution techniques: fusion, cognitive and in bore. Conclusions. Fusion technique shows the best results of the effectiveness of the diagnosis of csPCa with repeated biopsy. According to the literature, various methods of performing fusion biopsies are comparable to each other.
- 13 January 2026
- Published by Rostov State Medical University in Urology Herald
- Vol. 13 (6) , 106-115
Open AccessRepeat biopsy techniques and outcomes in the detection of clinically significant prostate cancer
Introduction. Prostate biopsy remains the definitive standard for confirming malignancy in the prostate. However, a negative initial biopsy does not rule out the presence of prostate cancer (PCa) during subsequent follow-up. This review provides an overview of current repeat biopsy techniques and assesses their diagnostic accuracy for clinically significant PCa (csPCa). Objective. To study various methods of repeated biopsy and evaluate the results of diagnosis of csPCa. Materials & Methods. A review of PubMed, eLibrary electronic databases was conducted from 2000 to 2024 to identify all relevant studies. The electronic search was limited to Russian and English, and the keywords used were: repeat prostate biopsy, clinically significant prostate cancer, fusion biopsy. Results. Currently, the following techniques can be used to perform a repeat prostate biopsy: saturation biopsy, micro-ultrasound, histoscanning and fusion biopsy. Saturation biopsy is associated with an increase in the number of complications, histoscanning has not shown high efficiency, micro-ultrasound is not so common and is limited by the number of studies. The advantage of diagnosing csPCa in patients with a previous negative histological conclusion is currently behind fusion biopsy. One of the advantages is the ability to choose one of three execution techniques: fusion, cognitive and in bore. Conclusions. Fusion technique shows the best results of the effectiveness of the diagnosis of csPCa with repeated biopsy. According to the literature, various methods of performing fusion biopsies are comparable to each other.
- Open Access
- 18 December 2025
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 21 (3) , 82-90
Results of using targeted methods in repeat prostate biopsy in patients with negative results of primary systemic biopsy
Background. Biopsy is the standard for prostate cancer (PCa) diagnostics. The false negative rate of 12-core biopsy is about 30 %. To improve the quality of detection of clinically significant PCa (csPCa) (ISUP (International Society of Urological Pathology) score 2 or more) during repeat biopsy, it is possible to use targeted diagnostic methods, such as HistoScanning (HS), cognitive fusion biopsy, hardware fusion biopsy. Aim. To compare targeted prostate biopsy methods: HS, cognitive fusion, hardware fusion biopsy for the diagnosis of csPCa during repeat biopsy in patients with negative primary biopsy result. Materials and methods. A prospective comparative study was conducted. The study included 320 men with suspected PCa after negative primary biopsy. Median age was 68 years, PSA level was 9.1 ng/mL, prostate volume was 57 cm2, PSA density was 0.15 ng/ml/cm2. Patients were divided into three groups depending on repeat biopsy method: group 1 – HS, group 2 – cognitive fusion biopsy, group 3 – hardware fusion biopsy; the groups were comparable with each other. Results. PCa was diagnosed after repeat biopsy using HS, cognitive fusion, hardware fusion biopsy in 25.4, 45.5, 44.2 % of cases, respectively; csPCa was diagnosed in 4.5, 22.2, 18.2 % of cases, respectively. In all groups, PCa and csPCa were most often diagnosed with lesions in both target and standard biopsies. The use of targeting in the HS group did not provide an advantage in diagnostics. In the hardware fusion biopsy group, in the absence of cancer in standard cores, csPCa was diagnosed more often in targeted biopsies, compared with the cognitive fusion technique (11.8 % versus 7.5 %). With both fusion biopsy techniques, more malignant forms of PCa were diagnosed in targeted biopsies, compared with standard cores, however, due to standard cores, 23.5 % of PCa cases were not missed, of which 3.75 % were csPCa. The use of transrectal cognitive fusion technique showed a comparable result with perineal hardware fusion biopsy for diagnosing transition zone cancer. Conclusion. The HS technique did not show advantages in diagnosing PCa during repeat biopsy. The use of cognitive fusion and hardware fusion techniques allows to improve diagnostics of both PCa and csPCa during repeat biopsy. According to our data, it is recommended to use targeted cores in addition to the standard ones. The use of cognitive fusion biopsy showed comparable results with hardware fusion in diagnostics of transition zone prostate cancer.
- 18 December 2025
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 21 (3) , 82-90
Open AccessResults of using targeted methods in repeat prostate biopsy in patients with negative results of primary systemic biopsy
Background. Biopsy is the standard for prostate cancer (PCa) diagnostics. The false negative rate of 12-core biopsy is about 30 %. To improve the quality of detection of clinically significant PCa (csPCa) (ISUP (International Society of Urological Pathology) score 2 or more) during repeat biopsy, it is possible to use targeted diagnostic methods, such as HistoScanning (HS), cognitive fusion biopsy, hardware fusion biopsy. Aim. To compare targeted prostate biopsy methods: HS, cognitive fusion, hardware fusion biopsy for the diagnosis of csPCa during repeat biopsy in patients with negative primary biopsy result. Materials and methods. A prospective comparative study was conducted. The study included 320 men with suspected PCa after negative primary biopsy. Median age was 68 years, PSA level was 9.1 ng/mL, prostate volume was 57 cm2, PSA density was 0.15 ng/ml/cm2. Patients were divided into three groups depending on repeat biopsy method: group 1 – HS, group 2 – cognitive fusion biopsy, group 3 – hardware fusion biopsy; the groups were comparable with each other. Results. PCa was diagnosed after repeat biopsy using HS, cognitive fusion, hardware fusion biopsy in 25.4, 45.5, 44.2 % of cases, respectively; csPCa was diagnosed in 4.5, 22.2, 18.2 % of cases, respectively. In all groups, PCa and csPCa were most often diagnosed with lesions in both target and standard biopsies. The use of targeting in the HS group did not provide an advantage in diagnostics. In the hardware fusion biopsy group, in the absence of cancer in standard cores, csPCa was diagnosed more often in targeted biopsies, compared with the cognitive fusion technique (11.8 % versus 7.5 %). With both fusion biopsy techniques, more malignant forms of PCa were diagnosed in targeted biopsies, compared with standard cores, however, due to standard cores, 23.5 % of PCa cases were not missed, of which 3.75 % were csPCa. The use of transrectal cognitive fusion technique showed a comparable result with perineal hardware fusion biopsy for diagnosing transition zone cancer. Conclusion. The HS technique did not show advantages in diagnosing PCa during repeat biopsy. The use of cognitive fusion and hardware fusion techniques allows to improve diagnostics of both PCa and csPCa during repeat biopsy. According to our data, it is recommended to use targeted cores in addition to the standard ones. The use of cognitive fusion biopsy showed comparable results with hardware fusion in diagnostics of transition zone prostate cancer.
- Open Access
- 30 July 2025
- Published by Rostov State Medical University in Urology Herald
- Vol. 13 (3) , 19-29
Overactive bladder following surgical intervention for benign prostatic hyperplasia: treatment outcomes in routine clinical practice
Introduction. Various surgical methods for the treatment of benign prostatic hyperplasia (BPH) effectively alleviate voiding symptoms and improve urinary flow quality. However, patient satisfaction often decreases due to the persistence of storage symptoms following surgical intervention.Objective. To determine the prevalence of persistent storage symptoms and overactive bladder (OAB), optimal approaches to the treatment of symptoms after surgical treatment of BPH in clinical practice.Materials & methods. The study included 94 patients aged 53 – 79 years who underwent surgery for BPH, with persistent storage symptoms in 1 – 3 months after surgery (IPSS-storage score ≥ 3). The patients underwent urodynamic examination. In the case of persistent symptoms without confirmed OAB, behavioral therapy was performed (group 1). In case of detrusor overactivity («dry» OAB), patients were prescribed medication solifenacin 5 mg daily (group 2), in case of terminal detrusor overactivity, urgent urinary incontinence («wet» OAB), combination therapy solifenacin 5 mg + mirabegron 50 mg (group 3) was prescribed.Results. Patient characteristics in the preoperative period showed no statistically significant differences between groups regarding age, urodynamic parameters, and lower urinary tract symptoms (LUTS) as assessed by the IPSS questionnaire. At the initiation of therapy, the median storage symptom scores were 4, 8, and 9 points in groups 1, 2, and 3, respectively. Both the behavioral and pharmacological therapy groups demonstrated a statistically significant reduction in the severity of storage symptoms over time (p < 0.001). After 12 weeks, the median storage symptom scores were 3 points in group 1, 4 points in group 2, and 6 points in group 3. Urgent incontinence was eliminated in group 3 after treatment. By 12 months after surgical treatment and drug therapy, the irritative symptoms and the number of nocturia episodes approach equal values in all groups (p > 0.05). Patients from the drug therapy groups showed high adherence to therapy, among them there were no significant side effects requiring discontinuation of therapy.Conclusion. The use of pharmacological therapy with M-cholinergic antagonists and/or β3-adrenoceptor agonists in the postoperative period in patients with confirmed detrusor overactivity contributes to a reduction in urgency symptoms and enhances patient treatment satisfaction. In the absence of detrusor overactivity or with an IPSS storage score ≤ 6, behavioral therapy represents a viable alternative to pharmacological treatment.
- 30 July 2025
- Published by Rostov State Medical University in Urology Herald
- Vol. 13 (3) , 19-29
Open AccessOveractive bladder following surgical intervention for benign prostatic hyperplasia: treatment outcomes in routine clinical practice
Introduction. Various surgical methods for the treatment of benign prostatic hyperplasia (BPH) effectively alleviate voiding symptoms and improve urinary flow quality. However, patient satisfaction often decreases due to the persistence of storage symptoms following surgical intervention.Objective. To determine the prevalence of persistent storage symptoms and overactive bladder (OAB), optimal approaches to the treatment of symptoms after surgical treatment of BPH in clinical practice.Materials & methods. The study included 94 patients aged 53 – 79 years who underwent surgery for BPH, with persistent storage symptoms in 1 – 3 months after surgery (IPSS-storage score ≥ 3). The patients underwent urodynamic examination. In the case of persistent symptoms without confirmed OAB, behavioral therapy was performed (group 1). In case of detrusor overactivity («dry» OAB), patients were prescribed medication solifenacin 5 mg daily (group 2), in case of terminal detrusor overactivity, urgent urinary incontinence («wet» OAB), combination therapy solifenacin 5 mg + mirabegron 50 mg (group 3) was prescribed.Results. Patient characteristics in the preoperative period showed no statistically significant differences between groups regarding age, urodynamic parameters, and lower urinary tract symptoms (LUTS) as assessed by the IPSS questionnaire. At the initiation of therapy, the median storage symptom scores were 4, 8, and 9 points in groups 1, 2, and 3, respectively. Both the behavioral and pharmacological therapy groups demonstrated a statistically significant reduction in the severity of storage symptoms over time (p < 0.001). After 12 weeks, the median storage symptom scores were 3 points in group 1, 4 points in group 2, and 6 points in group 3. Urgent incontinence was eliminated in group 3 after treatment. By 12 months after surgical treatment and drug therapy, the irritative symptoms and the number of nocturia episodes approach equal values in all groups (p > 0.05). Patients from the drug therapy groups showed high adherence to therapy, among them there were no significant side effects requiring discontinuation of therapy.Conclusion. The use of pharmacological therapy with M-cholinergic antagonists and/or β3-adrenoceptor agonists in the postoperative period in patients with confirmed detrusor overactivity contributes to a reduction in urgency symptoms and enhances patient treatment satisfaction. In the absence of detrusor overactivity or with an IPSS storage score ≤ 6, behavioral therapy represents a viable alternative to pharmacological treatment.
- Open Access
- 25 June 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (2)
Urodynamic parameters in patients with benign prostatic hyperplasia before surgery.
Introduction. Besides directly contributing to the pathogenesis of lower urinary tract symptoms, bladder outlet obstruction due to benign prostatic hyperplasia may lead to lower urinary tract dysfunction such as detrusor overactivity and decreased bladder contractility. Materials and methods. The analysis of urodynamic parameters of patients who underwent surgical treatment of prostatic hyperplasia was performed at the University Clinic of Urology of the Pirogov Russian National Research Medical University. A total of 340 patients who underwent urodynamic study (UDI) were included in the study. The following urodynamic parameters were assessed: presence or absence of detrusor overactivity (DO); maximum cystometric capacity; presence or absence of decreased bladder contractility; in patients who were able to undergo the pressure-flow study, the infravesical obstruction index and contractility index were calculated. Results. Of 340 patients who were indicated for surgical treatment of BPH, concomitant detrusor overactivity was noted in 84,1% of patients. Concominant detrusor underacrivity was found in 123 (36,4%) patients and only 19 (6%) patients had no significant impairment of detrusor function. Comparing patients with and without detrusor overactivity, a significant difference was found in the ratio of the severity of lower urinary tract symptoms (IPSS 23,9±6 vs 20±7,7, p<0.001), the bladder outlet obstruction index (72,6±33,2 vs 57,4±26,4, p=0,005) and functional bladder capacity (207,6±98,1 vs 355±123,5, p<0,001). When comparing patients with detrusor underactivity and normal contractility, a significant difference was revealed in the ratio of the severity of storage symptoms (10,4±2,9 vs 9,4±3,3), bladder capacity (276,3±134 vs 205,3±94,2), which is associated with a greater rate of detrusor overactivity in patients with BPH and the bladder outlet obstruction index (49,7±19,1 vs 82,2±32,8). Conclusions. These observations demonstrate the significant prevalence of concomitant bladder dysfunction, as well as the relationship of these disorders with lower urinary tract symptoms and urodynamic parameters.
- 25 June 2025
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 18 (2)
Open AccessUrodynamic parameters in patients with benign prostatic hyperplasia before surgery.
Introduction. Besides directly contributing to the pathogenesis of lower urinary tract symptoms, bladder outlet obstruction due to benign prostatic hyperplasia may lead to lower urinary tract dysfunction such as detrusor overactivity and decreased bladder contractility. Materials and methods. The analysis of urodynamic parameters of patients who underwent surgical treatment of prostatic hyperplasia was performed at the University Clinic of Urology of the Pirogov Russian National Research Medical University. A total of 340 patients who underwent urodynamic study (UDI) were included in the study. The following urodynamic parameters were assessed: presence or absence of detrusor overactivity (DO); maximum cystometric capacity; presence or absence of decreased bladder contractility; in patients who were able to undergo the pressure-flow study, the infravesical obstruction index and contractility index were calculated. Results. Of 340 patients who were indicated for surgical treatment of BPH, concomitant detrusor overactivity was noted in 84,1% of patients. Concominant detrusor underacrivity was found in 123 (36,4%) patients and only 19 (6%) patients had no significant impairment of detrusor function. Comparing patients with and without detrusor overactivity, a significant difference was found in the ratio of the severity of lower urinary tract symptoms (IPSS 23,9±6 vs 20±7,7, p<0.001), the bladder outlet obstruction index (72,6±33,2 vs 57,4±26,4, p=0,005) and functional bladder capacity (207,6±98,1 vs 355±123,5, p<0,001). When comparing patients with detrusor underactivity and normal contractility, a significant difference was revealed in the ratio of the severity of storage symptoms (10,4±2,9 vs 9,4±3,3), bladder capacity (276,3±134 vs 205,3±94,2), which is associated with a greater rate of detrusor overactivity in patients with BPH and the bladder outlet obstruction index (49,7±19,1 vs 82,2±32,8). Conclusions. These observations demonstrate the significant prevalence of concomitant bladder dysfunction, as well as the relationship of these disorders with lower urinary tract symptoms and urodynamic parameters.
- Open Access
- 2 March 2025
- Published by Rostov State Medical University in Urology Herald
- Vol. 13 (1) , 48-55
Affective disorders before and after laser enucleation of the prostate
Introduction. Lower urinary tract symptoms (LUTS), sexual dysfunction and psychological disorders coexist in the lives of older men. Evaluation of the prevalence of mood disorders and sexual dysfunction after surgical treatment is important to ensure a high quality of life for patients with LUTS.Objective. To analyse the incidence and severity of affective disorders in patients before and after laser enucleation of the prostate and to determine their association with LUTS and erectile dysfunction. Materials & methods. The study included 136 patients with benign prostatic hyperplasia treated with laser enucleation between 2018 and 2023. All the male participants were sexually active, and their erectile function was assessed at 11 points or higher according to the IIEF-5 scale. In addition to standard examination methods, all patients completed the IPSS, IIEF-5, and HADS questionnaires prior to surgery and 18 months postoperatively. The first stage of the study involved an investigation into the prevalence and severity of affective disorders both before and after surgical intervention, as well as determining their correlation with LUTS. The second stage focused on examining the relationship between affective disorders and sexual dysfunction. Patients were categorized into two groups based on the absence or presence of negative influence of LUTS on their quality of sexual life: group 1 (n = 70) — no influence, group 2 (n = 66) — influence is present.Results. Anxiety and depressive disorders of varying severity were found in 48 (35.3%) and 46 (33.8%) patients, respectively. It was found that the severity of both anxiety (r = 0.574; p < 0.001) and depressive disorders before surgical treatment correlated with LUTS (r = 0.590; p < 0.001), but after surgical treatment only anxiety disorder scores had a correlation with LUTS (r = 0.742; p < 0.001), and with irritative symptoms (r = 0.475; p < 0.001). Group 2 patients had lower IIEF-5 scores (18.0 vs. 21.0 points; p < 0.001) and were more likely to have anxiety and depressive disorders before surgical treatment (45.7 and 44.3% vs. 22.8 and 22.7%; p < 0.05), with significant improvement in erectile function and affective status after surgery, in contrast to group 1 patients, whose IIEF-5 scores and incidence of affective disorders did not change significantly.Conclusion. Patients with a predominantly irritative LUTS profile and a negative impact of urinary disturbances on sexual life are more susceptible to anxiety and depressive disorders. Consequently, evaluating their affective state is essential when treating men with LUTS to enhance their quality of life.
- 2 March 2025
- Published by Rostov State Medical University in Urology Herald
- Vol. 13 (1) , 48-55
Open AccessAffective disorders before and after laser enucleation of the prostate
Introduction. Lower urinary tract symptoms (LUTS), sexual dysfunction and psychological disorders coexist in the lives of older men. Evaluation of the prevalence of mood disorders and sexual dysfunction after surgical treatment is important to ensure a high quality of life for patients with LUTS.Objective. To analyse the incidence and severity of affective disorders in patients before and after laser enucleation of the prostate and to determine their association with LUTS and erectile dysfunction. Materials & methods. The study included 136 patients with benign prostatic hyperplasia treated with laser enucleation between 2018 and 2023. All the male participants were sexually active, and their erectile function was assessed at 11 points or higher according to the IIEF-5 scale. In addition to standard examination methods, all patients completed the IPSS, IIEF-5, and HADS questionnaires prior to surgery and 18 months postoperatively. The first stage of the study involved an investigation into the prevalence and severity of affective disorders both before and after surgical intervention, as well as determining their correlation with LUTS. The second stage focused on examining the relationship between affective disorders and sexual dysfunction. Patients were categorized into two groups based on the absence or presence of negative influence of LUTS on their quality of sexual life: group 1 (n = 70) — no influence, group 2 (n = 66) — influence is present.Results. Anxiety and depressive disorders of varying severity were found in 48 (35.3%) and 46 (33.8%) patients, respectively. It was found that the severity of both anxiety (r = 0.574; p < 0.001) and depressive disorders before surgical treatment correlated with LUTS (r = 0.590; p < 0.001), but after surgical treatment only anxiety disorder scores had a correlation with LUTS (r = 0.742; p < 0.001), and with irritative symptoms (r = 0.475; p < 0.001). Group 2 patients had lower IIEF-5 scores (18.0 vs. 21.0 points; p < 0.001) and were more likely to have anxiety and depressive disorders before surgical treatment (45.7 and 44.3% vs. 22.8 and 22.7%; p < 0.05), with significant improvement in erectile function and affective status after surgery, in contrast to group 1 patients, whose IIEF-5 scores and incidence of affective disorders did not change significantly.Conclusion. Patients with a predominantly irritative LUTS profile and a negative impact of urinary disturbances on sexual life are more susceptible to anxiety and depressive disorders. Consequently, evaluating their affective state is essential when treating men with LUTS to enhance their quality of life.
- Open Access
- 24 December 2024
- Published by "MedINK" Publishing House in Andrology and Genital Surgery
- Vol. 25 (4)
Influence of Penile Rehabilitation on the long-term results of Plaque Incision and Grafting in patients with Peyronie’s Disease
Introduction : The role of penile rehabilitation after surgical treatment of Peyronie’s disease remains debatable to this day. Objectives : to evaluate the impact of penile rehabilitation on the long-term results of plaque incision and grafting in patients with Peyronie’s Disease. Materials and Methods : a single-center, prospective, observational, uncontrolled study included 44 patients who underwent plaque incision and grafting in the period from 2012 to 2021. During the control examination, the state of erectile function was assessed using the IIEF-5 questionnaire, the presence or absence of postoperative complications (paresthesia of the glans penis, shortening of the penis, recurrence of curvature), and it was also clarified about the methods of penile rehabilitation that the patient used in the postoperative period (inhibitors phosphodiesterase type 5 use, vacuum therapy, traction therapy). Patients before surgery and during control examination underwent penile doppler ultrasound with pharmacological test (Alprostadil 10 mcg). 26 patients came to the follow-up examination. 18 patients were excluded from the study due to refusal to participate further. Patients were divided into two groups depending on the use of penile rehabilitation methods. The first group included 10 (38.5%) patients who did not use any of the recommended methods of penile rehabilitation in the postoperative period. The second group included 16 (61.5%) patients who used at least one of the recommended methods of penile rehabilitation. Results : the groups were comparable in terms of the main characteristics. The median follow-up period was 77 months in the first group and 94.5 months in the second group. The highest compliance was noted with regard to the use of PDE-5 inhibitors (100% of patients in the second group) and vacuum therapy (68.75% of the second group). In the first group, the frequency of venogenic dysfunction according to penile doppler ulrtasound was statistically significantly higher (p = 0.03). In the second group (patients who used penile rehabilitation methods), the IIEF-5 score was statistically significantly higher (p = 0.006), and the incidence of penile shortening and curvature recurrence was statistically significantly lower (p = 0.001 and p = 0.01, respectively). Conclusion : penile rehabilitation significantly improves the long-term functional results of plaque incision and grafting in patients with Peyronie’s disease.
- 24 December 2024
- Published by "MedINK" Publishing House in Andrology and Genital Surgery
- Vol. 25 (4)
Open AccessInfluence of Penile Rehabilitation on the long-term results of Plaque Incision and Grafting in patients with Peyronie’s Disease
Introduction : The role of penile rehabilitation after surgical treatment of Peyronie’s disease remains debatable to this day. Objectives : to evaluate the impact of penile rehabilitation on the long-term results of plaque incision and grafting in patients with Peyronie’s Disease. Materials and Methods : a single-center, prospective, observational, uncontrolled study included 44 patients who underwent plaque incision and grafting in the period from 2012 to 2021. During the control examination, the state of erectile function was assessed using the IIEF-5 questionnaire, the presence or absence of postoperative complications (paresthesia of the glans penis, shortening of the penis, recurrence of curvature), and it was also clarified about the methods of penile rehabilitation that the patient used in the postoperative period (inhibitors phosphodiesterase type 5 use, vacuum therapy, traction therapy). Patients before surgery and during control examination underwent penile doppler ultrasound with pharmacological test (Alprostadil 10 mcg). 26 patients came to the follow-up examination. 18 patients were excluded from the study due to refusal to participate further. Patients were divided into two groups depending on the use of penile rehabilitation methods. The first group included 10 (38.5%) patients who did not use any of the recommended methods of penile rehabilitation in the postoperative period. The second group included 16 (61.5%) patients who used at least one of the recommended methods of penile rehabilitation. Results : the groups were comparable in terms of the main characteristics. The median follow-up period was 77 months in the first group and 94.5 months in the second group. The highest compliance was noted with regard to the use of PDE-5 inhibitors (100% of patients in the second group) and vacuum therapy (68.75% of the second group). In the first group, the frequency of venogenic dysfunction according to penile doppler ulrtasound was statistically significantly higher (p = 0.03). In the second group (patients who used penile rehabilitation methods), the IIEF-5 score was statistically significantly higher (p = 0.006), and the incidence of penile shortening and curvature recurrence was statistically significantly lower (p = 0.001 and p = 0.01, respectively). Conclusion : penile rehabilitation significantly improves the long-term functional results of plaque incision and grafting in patients with Peyronie’s disease.
- Open Access
- 25 September 2024
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 17 (3)
Complications and urinary disorders after surgical treatment of BPH by laser enucleation.
Introduction. Benign prostatic hyperplasia (BPH) is a common disease in elderly men, manifested by symptoms of the lower urinary tract. Drug treatment of BPH often allows you to delay or even avoid performing surgery. Laser endoscopic enucleation, which shows excellent functional results regardless of the patient's age and prostate volume, can be considered the modern «gold standard» of surgical treatment of BPH. However, complications and urinary disorders after surgical treatment are also inherent in this method. The purpose of this article was to systematize information on the quality of urination and the preservation of symptoms of the lower urinary tract in patients after endoscopic enucleation of BPH. Materials and methods. The literature review was compiled from analyzed materials from three scientific databases (PubMed, Scopus and Web of Science, eLibrary), focusing on the following keywords: «laser enucleation», «lower urinary tract symptoms», «complications after enucleation of prostate». Results. The obtained results of many studies allow us to state the existence of a new «gold standard» of surgical treatment of BPH and to consider the possibility of introducing HoLEP into the standards of medical care for urological patients with BPH. In the postoperative period, long-term monitoring of patients is necessary. Currently, there are no clear standards for the necessary examinations and the timing of their implementation in the postoperative period. Conclusion. Laser enucleation is a reliable method of surgical treatment of LUTS due to BPH.
- 25 September 2024
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 17 (3)
Open AccessComplications and urinary disorders after surgical treatment of BPH by laser enucleation.
Introduction. Benign prostatic hyperplasia (BPH) is a common disease in elderly men, manifested by symptoms of the lower urinary tract. Drug treatment of BPH often allows you to delay or even avoid performing surgery. Laser endoscopic enucleation, which shows excellent functional results regardless of the patient's age and prostate volume, can be considered the modern «gold standard» of surgical treatment of BPH. However, complications and urinary disorders after surgical treatment are also inherent in this method. The purpose of this article was to systematize information on the quality of urination and the preservation of symptoms of the lower urinary tract in patients after endoscopic enucleation of BPH. Materials and methods. The literature review was compiled from analyzed materials from three scientific databases (PubMed, Scopus and Web of Science, eLibrary), focusing on the following keywords: «laser enucleation», «lower urinary tract symptoms», «complications after enucleation of prostate». Results. The obtained results of many studies allow us to state the existence of a new «gold standard» of surgical treatment of BPH and to consider the possibility of introducing HoLEP into the standards of medical care for urological patients with BPH. In the postoperative period, long-term monitoring of patients is necessary. Currently, there are no clear standards for the necessary examinations and the timing of their implementation in the postoperative period. Conclusion. Laser enucleation is a reliable method of surgical treatment of LUTS due to BPH.
- Open Access
- 29 April 2024
- Published by Rostov State Medical University in Urology Herald
- Vol. 12 (2) , 43-57
Efficacy of Phlogenzyme® in men following transurethral laser enucleation of prostate hyperplasia: results of a randomized trial
Introduction. The most advanced and effective method of surgical treatment for benign prostatic hyperplasia (BPH) is transurethral laser enucleation of the prostate (tLEP). Recently, there has been a growing interest in exploring new approaches to reduce the risk of complications following tLEP.Objective. To evaluate the efficacy of using Phlogenzym® as part of a comprehensive treatment plan for patients following tLEP to reduce dysuria (urinary discomfort), leukocyturia (white blood cells in urine), and prevent infectious and fibrosis-related complications.Materials & methods. An open-label, randomized trial enrolled 105 patients undergoing tLEP. The patients were randomly assigned to two groups: the study group (n=50) received standard postoperative care in combination with Phlogenzym® for 30 days, while the control group (n=55) received standard care (α1-adrenergic blocker for 28 days) only. uring the follow-up period, which lasted for 1, 3, and 6 months postoperatively, complaints were evaluated using the IPSS-QoL, and IIEF-5 questionnaires, as well as indicators of urinalysis and urine culture, prostate volume measurements, residual urine volume, and uroflowmetry data.Results. Among all patients, the median preoperative values for prostate volume, IPSS, QoL score, and median peak urine flow rate were 90 cc, 18 points, 5 points, and 7.9 mL/s, respectively, with no significant differences between the groups. One month after surgery, in the study group, there was a more significant decrease in prostate volume (57% vs. 41%), although this difference was not statistically significant (p > 0.05). At the 6-month follow-up, bacteriuria was less common in the study group (42% vs. 67%), and there was a consistent trend toward a reduction in the incidence of fibrous complications, although these differences were not statistically significant either (p > 0.05). No adverse events occurred during the follow-up period.Conclusion. Our experience suggests that the use of Phlogenzym® is safe during the postoperative period following tLEP surgery. The use of this drug leads to a reduction in prostate volume postoperatively and significantly reduces the bacteriuria by the six-month follow-up. Additionally, there is a persistent positive trend towards reducing the overall incidence of fibrotic complications in the surgical site. The results achieved and the absence of significant side effects characterize Phlogenzym® as having a favorable clinical profile.
- 29 April 2024
- Published by Rostov State Medical University in Urology Herald
- Vol. 12 (2) , 43-57
Open AccessEfficacy of Phlogenzyme® in men following transurethral laser enucleation of prostate hyperplasia: results of a randomized trial
Introduction. The most advanced and effective method of surgical treatment for benign prostatic hyperplasia (BPH) is transurethral laser enucleation of the prostate (tLEP). Recently, there has been a growing interest in exploring new approaches to reduce the risk of complications following tLEP.Objective. To evaluate the efficacy of using Phlogenzym® as part of a comprehensive treatment plan for patients following tLEP to reduce dysuria (urinary discomfort), leukocyturia (white blood cells in urine), and prevent infectious and fibrosis-related complications.Materials & methods. An open-label, randomized trial enrolled 105 patients undergoing tLEP. The patients were randomly assigned to two groups: the study group (n=50) received standard postoperative care in combination with Phlogenzym® for 30 days, while the control group (n=55) received standard care (α1-adrenergic blocker for 28 days) only. uring the follow-up period, which lasted for 1, 3, and 6 months postoperatively, complaints were evaluated using the IPSS-QoL, and IIEF-5 questionnaires, as well as indicators of urinalysis and urine culture, prostate volume measurements, residual urine volume, and uroflowmetry data.Results. Among all patients, the median preoperative values for prostate volume, IPSS, QoL score, and median peak urine flow rate were 90 cc, 18 points, 5 points, and 7.9 mL/s, respectively, with no significant differences between the groups. One month after surgery, in the study group, there was a more significant decrease in prostate volume (57% vs. 41%), although this difference was not statistically significant (p > 0.05). At the 6-month follow-up, bacteriuria was less common in the study group (42% vs. 67%), and there was a consistent trend toward a reduction in the incidence of fibrous complications, although these differences were not statistically significant either (p > 0.05). No adverse events occurred during the follow-up period.Conclusion. Our experience suggests that the use of Phlogenzym® is safe during the postoperative period following tLEP surgery. The use of this drug leads to a reduction in prostate volume postoperatively and significantly reduces the bacteriuria by the six-month follow-up. Additionally, there is a persistent positive trend towards reducing the overall incidence of fibrotic complications in the surgical site. The results achieved and the absence of significant side effects characterize Phlogenzym® as having a favorable clinical profile.
- Open Access
- 4 March 2024
- Published by Rostov State Medical University in Urology Herald
- Vol. 12 (1) , 45-59
Optimal intestinal graft selection for reconstruction of extended ureteral stricture: an animal model study
Introduction. The prevalence of patients with extended ureteral strictures has been steadily increasing over the past decades. When it is not possible to perform reconstruction with the tissues of the urinary system, the best solution is intestinal replacement plasty. However, despite the great world experience, the search for the optimal method of intestinal reconstruction does not stop, which determines the relevance of conducting an experimental prospective study.Objective. To evaluate morphological changes in renal parenchyma after ureteral replacement reconstruction by segments of small and large intestine.Materials & methods. Fifteen white giant rabbits (6-months-old, weighing 5 kg) were divided into three groups. Group A (n = 5) underwent small intestine [ilealplasty] replacement plasty. Group B (n = 5) double-flap ileoplasty using the Yang-Monti technique. Group C (n = 5) – large intestine [coloplasy] ureteral reconstruction. Before the operation and before withdrawal from the experiment, the level of creatinine and electrolytes was assessed, kidney ultrasound was performed on days 2, 5, 10. Excretory urography was performed to assess the patency of the anastomoses. Animals were withdrawn from the experiment from day 10 to 30. The material used for morphological study included kidneys from the operated and intact sides, proximal and distal anastomoses.Results. No increase in creatinine level, metabolic disorders were detected in animals. According to ultrasound data, hydronephrosis developed in all animals on day 2 and remained unchanged during the entire follow-up. Group A: no complications were detected. Histologically, the renal parenchyma showed moderate signs of chronic inflammation, single foci of lymphoid infiltration, but there were no irreversible processes in the form of necrosis and sclerosis. Group B: complications — stricture in the anastomosis area of the detubularised fragments and necrosis of the small intestine due to compression of the mesentery by the graft vascular stem. Histologically there were marked dilatation of the tubules at all levels, enlargement of the Bowman-Shumlansky capsule, as well as signs of moderate inflammatory process, there were hydropic and hyaline-droplet dystrophy, tubular necrosis foci. Group C: complications — accumulation of a significant amount of grit, mucus, and fibrin in the colocystoanastomosis area. Histologically, the renal parenchyma showed a marked inflammatory process, in particular, purulent inflammation with demarcation zones, infiltration with polymorphonuclear leukocytes and bacterial cells, foci of necrosis and sclerosis of both stroma and tubules, dilatation of tubules and Bowman-Schumlansky capsules.Conclusion. The use of an unchanged ileal-graft reconstruction of an extended ureteral defect showed acceptable histological results in an animal model, which confirms the feasibility of its use in clinical practice. The absence of foci of necrosis and fibrosis in the renal parenchyma indicates the preserved functional potential, which suggests the stabilization of renal function in the long term.
- 4 March 2024
- Published by Rostov State Medical University in Urology Herald
- Vol. 12 (1) , 45-59
Open AccessOptimal intestinal graft selection for reconstruction of extended ureteral stricture: an animal model study
Introduction. The prevalence of patients with extended ureteral strictures has been steadily increasing over the past decades. When it is not possible to perform reconstruction with the tissues of the urinary system, the best solution is intestinal replacement plasty. However, despite the great world experience, the search for the optimal method of intestinal reconstruction does not stop, which determines the relevance of conducting an experimental prospective study.Objective. To evaluate morphological changes in renal parenchyma after ureteral replacement reconstruction by segments of small and large intestine.Materials & methods. Fifteen white giant rabbits (6-months-old, weighing 5 kg) were divided into three groups. Group A (n = 5) underwent small intestine [ilealplasty] replacement plasty. Group B (n = 5) double-flap ileoplasty using the Yang-Monti technique. Group C (n = 5) – large intestine [coloplasy] ureteral reconstruction. Before the operation and before withdrawal from the experiment, the level of creatinine and electrolytes was assessed, kidney ultrasound was performed on days 2, 5, 10. Excretory urography was performed to assess the patency of the anastomoses. Animals were withdrawn from the experiment from day 10 to 30. The material used for morphological study included kidneys from the operated and intact sides, proximal and distal anastomoses.Results. No increase in creatinine level, metabolic disorders were detected in animals. According to ultrasound data, hydronephrosis developed in all animals on day 2 and remained unchanged during the entire follow-up. Group A: no complications were detected. Histologically, the renal parenchyma showed moderate signs of chronic inflammation, single foci of lymphoid infiltration, but there were no irreversible processes in the form of necrosis and sclerosis. Group B: complications — stricture in the anastomosis area of the detubularised fragments and necrosis of the small intestine due to compression of the mesentery by the graft vascular stem. Histologically there were marked dilatation of the tubules at all levels, enlargement of the Bowman-Shumlansky capsule, as well as signs of moderate inflammatory process, there were hydropic and hyaline-droplet dystrophy, tubular necrosis foci. Group C: complications — accumulation of a significant amount of grit, mucus, and fibrin in the colocystoanastomosis area. Histologically, the renal parenchyma showed a marked inflammatory process, in particular, purulent inflammation with demarcation zones, infiltration with polymorphonuclear leukocytes and bacterial cells, foci of necrosis and sclerosis of both stroma and tubules, dilatation of tubules and Bowman-Schumlansky capsules.Conclusion. The use of an unchanged ileal-graft reconstruction of an extended ureteral defect showed acceptable histological results in an animal model, which confirms the feasibility of its use in clinical practice. The absence of foci of necrosis and fibrosis in the renal parenchyma indicates the preserved functional potential, which suggests the stabilization of renal function in the long term.